• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Unlocking the power of health care AI tools through clinical validation


Clinical validation balances the importance of innovation while ensuring safety and reliability

Artificial intelligence (AI) has emerged as a game-changing technology with the potential to revolutionize health care. Specifically, artificial intelligence-based predictive and prognostic tools in the field of personalized medicine, are an exciting area that AI is actively tapping into. However, in order to effectively leverage and advance these AI tools, there is a crucial need to approach the adoption with caution by taking the necessary actions through rigorous research to ensure these tools are clinically validated.

Tim Showalter, MD, MPH: ©ArteraAI

Tim Showalter, MD, MPH: ©ArteraAI

As the health care industry continues to navigate the adoption of these tools, the larger the role federal agencies are taking to regulate the use of AI, placing a greater emphasis on the need for clinical validation of predictive and prognostic models. One way that the health care industry can work with federal agencies on ensuring the ethical adoption of AI is to focus on the need for clinical validation, as it balances the importance of innovation while ensuring safety and reliability.

Caution in AI Adoption:

While the promise of AI in health care is enticing, it is essential to proceed with caution. Practicing clinicians and health care professionals have a responsibility to prioritize patient safety and well-being. It is paramount to recognize that the effectiveness and safety of AI tools must be thoroughly validated through robust research and clinical trials before integrating them into routine clinical practice.

The process of clinical validation involves rigorously testing AI algorithms against large and diverse datasets, comparing their performance to other standard tools and ensuring that the technology functions reliably across different patient populations. By conducting comprehensive research, we can address concerns related to algorithmic bias, data privacy, and potential unintended consequences, thereby mitigating the risks associated with AI adoption.

Unlocking the Power of AI in Health care:

AI holds tremendous promise in transforming health care delivery, enhancing patient outcomes, and improving operational efficiencies. Its ability to analyze vast amounts of data, identify patterns and generate insights that exceed human capacity is particularly valuable in health care settings.

One of the most rapidly advancing applications of AI in health care is in treatment decision-making. AI-enabled predictive and prognostic tools serve as a critical aid in determining more personalized treatment care. Through the integration of AI, physicians can benefit from advanced diagnostic and prognostic capabilities, streamlined workflows, and personalized treatment recommendations. For example, recent data published in the New England Journal of Medicine validated that an AI-derived model can identify prostate cancer patients who are likely to benefit from short-term androgen deprivation therapy (ADT). Using this technology, clinicians are able to determine which of their patients will most likely benefit from short-term ADT therapy, allowing for more informed decision making for both patients and clinicians.

By harnessing the power of AI, these tools have the potential to optimize patient care, improve outcomes, and drive advancements in medical research and precision medicine. However, caution is essential in the adoption of these tools through rigorous validation, ethical considerations, collaboration, and interdisciplinary efforts to ensure responsible and effective use of these tools in a clinical setting.

Ethical Considerations

Ethics and transparency are crucial when incorporating AI into health care. Physicians must be vigilant in ensuring that AI tools are developed using high-quality, unbiased data that adequately represents the diverse patient populations we serve. AI-based tools should be designed and validated to be fair and unbiased across different patient populations. Bias can arise from skewed training data or underlying assumptions in the algorithm, leading to disparities in predictions. Thus, further emphasizing that efforts should be made to identify and mitigate biases, ensuring that the tools do not discriminate against certain demographic groups or perpetuate health care disparities.

Furthermore, transparency and explainability are important for trust-building, enabling clinicians to make informed decisions and patients to understand the basis of predictive and prognostic information provided. Necessary actions taken to ensure transparency is incorporated within the algorithmic decision-making is essential, enabling physicians to understand how AI arrives at its recommendations and facilitating trust between physicians, patients, and AI systems.

Ongoing Evaluation and Continuous Learning

AI technologies are constantly evolving, and as practicing physicians, we must be proactive in evaluating their performance and embracing continuous learning while conducting continual accountability monitoring. Regular assessments should be conducted to ensure that the tools remain accurate, reliable, and up to date. Accountability mechanisms should be in place to address any shortcomings, errors, or adverse consequences resulting from the use of these tools. Monitoring the real-world performance of AI tools and conducting annual studies can help identify potential limitations or biases that may not have been evident during the initial clinical validation phase. By actively engaging in research and staying updated on the latest advancements, we can optimize the integration of AI into our clinical practice and ensure its long-term efficacy.

Collaboration and Interdisciplinary Efforts

The successful adoption of AI in health care requires collaboration between physicians, researchers, technologists, and policymakers. By fostering interdisciplinary partnerships, we can harness the collective expertise to refine AI algorithms, validate their clinical utility, and address the ethical and regulatory challenges associated with their implementation. As practicing physicians, your insights and experiences are invaluable in guiding the development and deployment of AI tools that truly benefit patient care.

Lastly, clinical validation plays a crucial role in building trust and acceptance among health care professionals and stakeholders. Validated predictive and prognostic tools provide a transparent and evidence-based foundation for clinical decision-making, increasing confidence in the tool's predictions and recommendations. Clinicians are more likely to adopt and integrate validated tools into their practice when they have confidence in their accuracy and utility. Once the technology is clinically validated, physicians and healthcare organizations can maximize the benefits of AI while minimizing risks and potential pitfalls.

Tim Showalter, MD, MPH, is a radiation oncologist and cancer researcher who serves as vice president of clinical development at ArteraAI. In this role, he provides scientific and clinical leadership for product development and evidence generation needed to bring ArteraAI biomarkers into clinical use. Tim maintains a part-time clinical practice at the University of Virginia as professor of radiation oncology.

Related Videos
Kyle Zebley headshot
Kyle Zebley headshot
Kyle Zebley headshot
Michael J. Barry, MD
Hadi Chaudhry, President and CEO, CareCloud
Claire Ernst, JD, gives expert advice
Arien Malec